WPI 3659 (Desvenlafaxine Succinate Extended-Release 50 mg (base))
Pill with imprint WPI 3659 is Pink, Four-sided and has been identified as Desvenlafaxine Succinate Extended-Release 50 mg (base). It is supplied by Actavis Pharma, Inc..
Desvenlafaxine is used in the treatment of major depressive disorder; depression; adhd; anxiety; bipolar disorder (and more), and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Desvenlafaxine 50 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3659
Desvenlafaxine Succinate Extended-Release
- Imprint:
- WPI 3659
- Strength:
- 50 mg (base)
- Color:
- Pink
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- Serotonin-norepinephrine reuptake inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00591-3659
More about desvenlafaxine
- Desvenlafaxine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 936 Reviews
- Drug class: serotonin-norepinephrine reuptake inhibitors
Consumer resources
Other brands: Pristiq, Khedezla
Professional resources
- Desvenlafaxine Succinate (AHFS Monograph)
- Desvenlafaxine ER Tablets (FDA)
- Desvenlafaxine (Wolters Kluwer)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
